Improving Prognosis of Surrogate Assay for Breast Cancer Patients by Absolute Quantitation of Ki67 Protein Levels Using Quantitative Dot Blot (QDB) Method
2021 · Frontiers in Oncology · 11 citations
https://doi.org/10.3389/fonc.2021.737781
F
Fangrong Tang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
23
Papers
158
Citations
6
h-index
6
i10-index
Fangrong Tang is an academic researcher from Quanta Technology (United States). The author has contributed to research in topics: Breast Cancer Treatment Studies & Cancer Genomics and Diagnostics & Advanced Biosensing Techniques and Applications. The author has an h-index of 6, co-authored 20 publications.
ORCID: 0000-0003-4425-4443Papers by this author
worksCombined Use of cyclinD1 and Ki67 for Prognosis of Luminal-Like Breast Cancer Patients
2021 · Frontiers in Oncology · 11 citations
https://doi.org/10.3389/fonc.2021.737794
Validation of absolutely quantitated Ki67 and <scp>cyclinD1</scp> protein levels for prognosis of Luminal‐like breast cancer patients
2022 · Journal of Clinical Laboratory Analysis · 6 citations
https://doi.org/10.1002/jcla.24601
3D Visualization of the Dynamic Bidirectional Talk Between ER/PR and Her2 Pathways
2021 · Technology in Cancer Research & Treatment · 3 citations
https://doi.org/10.1177/15330338211065603
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat